Literature DB >> 15242882

The phenotype of motor neuropathies associated with BSCL2 mutations is broader than Silver syndrome and distal HMN type V.

Joy Irobi1, Peter Van den Bergh, Luciano Merlini, Christine Verellen, Lionel Van Maldergem, Ines Dierick, Nathalie Verpoorten, Albena Jordanova, Christian Windpassinger, Els De Vriendt, Veerle Van Gerwen, Michaela Auer-Grumbach, Klaus Wagner, Vincent Timmerman, Peter De Jonghe.   

Abstract

Silver syndrome is a rare autosomal dominant neurodegenerative disorder characterized by marked amyotrophy and weakness of small hand muscles and spasticity in the lower limbs. The locus for Silver syndrome (SPG17) was assigned to a 13 cM region on chromosome 11q12-q14 in a single large pedigree. We recently found heterozygous mutations in the Berardinelli-Seip congenital lipodystrophy (BSCL2, seipin) gene causing SPG17 and distal hereditary motor neuropathy type V (distal HMN V). Here we report the clinical features of two families with heterozygous BSCL2 mutations. Interestingly, both families show a clinical phenotype different from classical Silver syndrome, and in some patients the phenotype is also different from distal HMN V. Patients in the first family had marked spasticity in the lower limbs and very striking distal amyotrophy that always started in the legs. Patients in the second family had distal amyotrophy sometimes starting and predominating in the legs, but no pyramidal tract signs. These observations broaden the clinical phenotype of disorders associated with BSCL2 mutations, having consequences for molecular genetic testing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15242882     DOI: 10.1093/brain/awh232

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  28 in total

1.  ALS and MMN mimics in patients with BSCL2 mutations: the expanding clinical spectrum of SPG17 hereditary spastic paraplegia.

Authors:  Thomas Musacchio; Ann-Kathrin Zaum; Nurcan Üçeyler; Claudia Sommer; Nora Pfeifroth; Karlheinz Reiners; Erdmute Kunstmann; Jens Volkmann; Simone Rost; Stephan Klebe
Journal:  J Neurol       Date:  2016-10-13       Impact factor: 4.849

Review 2.  Unraveling the genetics of distal hereditary motor neuronopathies.

Authors:  Joy Irobi; Ines Dierick; Albena Jordanova; Kristl G Claeys; Peter De Jonghe; Vincent Timmerman
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

3.  Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease.

Authors:  Chi-Hui Tang; Je-Wook Lee; Michael G Galvez; Liliane Robillard; Sara E Mole; Harold A Chapman
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

4.  Clinical and histopathological study of Charcot-Marie-Tooth neuropathy with a novel S90W mutation in BSCL2.

Authors:  B-O Choi; M-H Park; K W Chung; H-M Woo; H Koo; H-K Chung; K-G Choi; K D Park; H J Lee; Y S Hyun; S K Koo
Journal:  Neurogenetics       Date:  2012-11-10       Impact factor: 2.660

Review 5.  Genetics of motor neuron disease.

Authors:  Ludo Van Den Bosch; Vincent Timmerman
Journal:  Curr Neurol Neurosci Rep       Date:  2006-09       Impact factor: 5.081

6.  Celia's encephalopathy and c.974dupG in BSCL2 gene: a hidden change in a known variant.

Authors:  Sofía Sánchez-Iglesias; Melissa Crocker; Mar O'Callaghan; Alejandra Darling; Angels García-Cazorla; Rosario Domingo-Jiménez; Ana Castro; Antía Fernández-Pombo; Álvaro Ruibal; Pablo Aguiar; Miguel Garrido-Pumar; Antonio Rodríguez-Núñez; Julián Álvarez-Escudero; Rebecca J Brown; David Araújo-Vilar
Journal:  Neurogenetics       Date:  2019-03-23       Impact factor: 2.660

7.  The first Italian family with evidence of pyramidal impairment as phenotypic manifestation of Silver syndrome BSCL2 gene mutation.

Authors:  Gianfranco Cafforio; Rosanna Calabrese; Nicola Morelli; Michelangelo Mancuso; Selina Piazza; Andrea Martinuzzi; Maria Teresa Bassi; Francesco Crippa; Gabriele Siciliano
Journal:  Neurol Sci       Date:  2008-07-09       Impact factor: 3.307

8.  Re-analysis of an original CMTX3 family using exome sequencing identifies a known BSCL2 mutation.

Authors:  Rabia Chaudhry; Aditi Kidambi; Megan Hwa Brewer; Anthony Antonellis; Katherine Mathews; Garth Nicholson; Marina Kennerson
Journal:  Muscle Nerve       Date:  2013-03-29       Impact factor: 3.217

9.  Targeted next-generation sequencing improves diagnosis of hereditary spastic paraplegia in Chinese patients.

Authors:  Cong Lu; Li-Xi Li; Hai-Lin Dong; Qiao Wei; Zhi-Jun Liu; Wang Ni; Aaron D Gitler; Zhi-Ying Wu
Journal:  J Mol Med (Berl)       Date:  2018-06-11       Impact factor: 4.599

10.  A novel 16p locus associated with BSCL2 hereditary motor neuronopathy: a genetic modifier?

Authors:  Esther Brusse; Danielle Majoor-Krakauer; Bianca M de Graaf; Gerhard H Visser; Sigrid Swagemakers; Agnita J W Boon; Ben A Oostra; Aida M Bertoli-Avella
Journal:  Neurogenetics       Date:  2009-04-24       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.